Home›Stock Screener›Vilin Bio Med

Vilin Bio Med Share Price Today | Stock Price & Vilin Bio Med Share Screener

VILINBIO Pharmaceuticals

Track the current Vilin Bio Med share price and stock price live with TickJournal's free stock screener. Check Vilin Bio Med 52-week for the annual price range and momentum. Use the Vilin Bio Med stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Vilin Bio Med opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹8 and net income of ₹1, with EBITDA of ₹2, an operating margin of 8.0% and a profit margin of 12.5%.

Vilin Bio Med Market Cap ₹86.16 Cr.
VILINBIO P/E Ratio (TTM) 42.74
Vilin Bio Med P/B Ratio 2.89
EPS (TTM) ₹1.26
Dividend Yield -
Debt to Equity 0.20
VILINBIO 52 Week High -
Vilin Bio Med 52 Week Low -
Operating Margin 8.00%
Profit Margin 12.50%
VILINBIO Revenue (TTM) ₹8.00
EBITDA ₹2.00
Net Income ₹1.00
Total Assets ₹35.00
Total Equity ₹28.00

Vilin Bio Med Share Price Chart

Track the current stock price of Vilin Bio Med with an interactive chart. Analyse VILINBIO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Vilin Bio Med stock quote in one place.

Vilin Bio Med Company Profile - Fundamental Screener

Screen Vilin Bio Med company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for VILINBIO shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0L4V01013.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE0L4V01013

Vilin Bio Med Balance Sheet Screener

Screen VILINBIO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹35, up from ₹28 in 2025.

Latest statistics put total assets at ₹35 and shareholder funds at ₹28, with a leverage ratio of 0.20.

Item 2026 2025 2024 2023 2022 2021 2020

Assets

Total Assets 35 28 32 18 14 14 14
Current Assets 27 20 19 8 12 12 12
Fixed Assets 3 1 1 2 2 2 2

Liabilities

Total Liabilities 0 0 0 0 0 0 0
Current Liabilities 0 0 0 1 1 1 0
Non-Current Liabilities 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 28 23 23 11 7 7 7
Share Capital 15 14 14 10 3 3 3
Reserves & Surplus 13 9 9 1 4 4 4

Vilin Bio Med Income Statement Screener - Profit & Revenue Analysis

Screen Vilin Bio Med income statement and profit fundamentals. Analyze VILINBIO quarterly results. Vilin Bio Med reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹8 and net profit was ₹1, equal to earnings per unit of ₹2.20, at an operating margin of 8%.

In that period expenses were ₹7, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹42 and net profit of ₹2.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Revenue and Expenses

Revenue 8 42 15 16 12 11 12 17
Expenses 7 39 14 15 10 10 11 16

Operating Costs and Margins

EBITDA 2 3 1 1 3 1 1 1
Operating Profit % 8.00% 8.00% 5.00% 5.00% 21.00% 7.00% 7.00% 5.00%
Depreciation 0 0 0 0 0 0 0 0
Interest 0 0 1 1 1 1 0 0

Profit and Earnings

Profit Before Tax 1 3 0 0 2 0 0 0
Tax 0 1 0 0 1 0 0 0
Net Profit 1 2 0 0 1 0 0 0
EPS 2.20 1.26 0.16 0.12 1.25 0.10 0.15 0.20

Vilin Bio Med Cash Flow Screener - Liquidity Fundamentals

Screen VILINBIO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1, and net cash flow was an inflow of ₹1.

Over the same period, investing activities provided ₹0 and financing activities provided ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March

Cash from Operations and Investing

Operating Activities 1 0 -7 -2 0 -1 -2
Investing Activities 0 -1 0 0 0 0 0

Financing and Net Cash

Financing Activities 1 -5 9 2 0 1 2
Net Cash Flow 1 -6 2 0 0 0 0

Vilin Bio Med Shareholding Pattern Screener

See Vilin Bio Med shareholding pattern with promoter, FII, and DII holdings. Check Vilin Bio Med promoter holding and ownership changes for VILINBIO on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 56.65%, foreign institutions 0.00%, domestic institutions 0.00% and the public 33.08%, spread across 382 shareholders.

The shareholder count was 382 in 2026-Jun, compared with 400 in 2026-May.

Item 2026-Jun 2026-May 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Sept

Promoter Holding

Promoter Holding 56.65% 56.65% 59.57% 63.65% 63.89% 63.89% 63.89% 64.09%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 33.08% 33.06% 30.19% 33.95% 33.55% 33.49% 34.18% 34.47%
Other Holding 10.27% 10.30% 10.24% 2.39% 2.57% 2.62% 1.94% 1.45%
Shareholder Count 382 400 421 462 476 492 551 581

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Vilin Bio Med. Vilin Bio Med dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Vilin Bio Med.

Vilin Bio Med Stock Index Membership - Nifty & Sensex

See which indices include Vilin Bio Med stock. Check VILINBIO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Vilin Bio Med is not part of any tracked indices.
Only major market indices are tracked in our system.

Vilin Bio Med Market Events Screener - Corporate Actions

Get Vilin Bio Med corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Vilin Bio Med stock events that may affect VILINBIO share price, along with derivatives, futures and options activity and sector gainers.

7 corporate actions are listed, the most recent entry being Extraordinary General Meeting dated October 15, 2026, with a record date of October 15, 2026.

It is followed by Quarterly Result Announcement dated May 30, 2026 and Extraordinary General Meeting dated February 9, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-15 2026-10-15 Extraordinary General Meeting NA -8.73%
2026-05-30 2026-05-30 Quarterly Result Announcement NA -4.02%
2026-02-09 2026-02-09 Extraordinary General Meeting NA 35.85%
2025-11-12 2025-11-12 Quarterly Result Announcement NA -5.85%
2025-05-17 2025-05-17 Quarterly Result Announcement NA 4.73%
2024-10-30 2024-10-30 Quarterly Result Announcement NA -6.15%
2024-09-21 2024-09-21 Annual General Meeting NA -4.24%

Vilin Bio Med Competitors Screener - Peer Stocks Comparison

Screen VILINBIO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 441,478 36.83 61,674 12.69% 11,565 47.42
Divis Laboratories 247,709 86.00 11,067 13.95% 2,568 58.71
Torrent Pharmaceuticals 183,280 86.72 13,886 20.34% 2,138 48.14
Zydus Life Science 115,940 25.96 27,658 17.64% 5,026 61.81
Cipla 109,853 33.29 29,045 2.24% 3,870 44.03
Laurus Labs 106,771 98.39 6,868 22.01% 890 58.00
Mankind Pharma 103,575 50.84 14,636 14.85% 1,938 64.24
Dr Reddys Laboratories 103,467 32.77 35,059 3.90% 4,158 69.59
Aurobindo Pharma 96,485 26.41 34,145 5.56% 3,503 54.69
Lupin 93,767 16.97 29,039 26.75% 5,356 34.02

Vilin Bio Med Company Announcements - News & Reports Screener

Screen VILINBIO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 42.74 and the P/B ratio is 2.89, with earnings per unit of ₹1.26. Market capitalisation stands at ₹86.16 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 7, 2026. This page covers 7 balance sheet periods, 8 income statement periods, 7 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.